SCHEMBL23865508

SCHEMBL23865508

CCOC(=O)N1CC2(CC(O)C2)C1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ POLB P06746 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ THRB P10828 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ RECQL P46063 1/20 0.39
▸ NOS3 P29474 1/20 0.37
▸ NOS2 P35228 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ GRM5 P41594 1/20 0.37
▸ MAPT P10636 2/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ ABL1 P00519 1/20 0.36
▸ RIN1 Q13671 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27375319 0.86 CHRM4 (0.46) GAATSHRALDH1A1KDM4EPOLB
SCHEMBL21384533 0.86 GAA (0.41) GAATSHRALDH1A1KDM4EPOLB
SCHEMBL21384366 0.86 GAA (0.41) GAATSHRALDH1A1KDM4EPOLB
SCHEMBL23368109 0.86 CHRM4 (0.46) GAATSHRALDH1A1KDM4EPOLB
SCHEMBL23859720 0.85 LMNA (0.49) TSHRALDH1A1POLBSMN1; SMN2ATM
SCHEMBL20414854 0.82 GAA (0.47) GAATSHRALDH1A1KDM4EPOLB
SCHEMBL25839456 0.81 USP2 (0.41) TSHRALDH1A1CYP1A2CYP3A4
SCHEMBL21401618 0.77 TSHR (0.44) GAATSHRALDH1A1KDM4EPOLB
SCHEMBL29424723 0.77 TSHR (0.44) GAATSHRALDH1A1KDM4EPOLB
SCHEMBL23704607 0.75 SMN1; SMN2 (0.55) GAAHTTSMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192654-A1 PIPERAZINE AZASPIRO DERIVATIVES PFIZER INC. 2023-06-22 — — US disclosed
EP-3331528-B1 MUSCARINIC AGONISTS HEPTARES THERAPEUTICS LTD (GB) 2021-09-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230192654-A1 PIPERAZINE AZASPIRO DERIVATIVES CHRM1, CHRM2, CHRM5 GAA 2320/4885TSHR 1403/4885ALDH1A1 1350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback